Panagiotakos Georgia, Tabar Viviane
Division of Neurosurgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, C711, New York, NY 10021, USA.
Curr Neurol Neurosci Rep. 2007 May;7(3):215-20. doi: 10.1007/s11910-007-0033-3.
The concept of brain tumor stem cells is gaining increased recognition in neuro-oncology. Until recently, the paradigm of a tumor-initiating stem cell was confined to hematopoietic malignancies where the hierarchical lineages of stem progenitor cells are well established. The demonstration of persistent stem cells and cycling progenitors in the adult brain, coupled with the expansion of the cancer stem cell concept to solid tumors, has led to the exploration of "stemness" within gliomas. Emerging data are highly suggestive of the subsistence of transformed multipotential cells within a glioma, with a subfraction of cells exhibiting increased efficiency at tumor initiation. However, data in support of true glioma stem cells are inconclusive to date, particularly with respect to functional characterization of these cells. Ongoing work aims at the identification of unique pathways governing self-renewal of these putative stem cells and at their validation as ultimate therapeutic targets.
脑肿瘤干细胞的概念在神经肿瘤学中越来越受到认可。直到最近,肿瘤起始干细胞的范例还局限于造血系统恶性肿瘤,在那里干细胞祖细胞的层级谱系已得到充分确立。成体脑中持续存在的干细胞和循环祖细胞的证实,以及癌症干细胞概念向实体瘤的扩展,促使人们对胶质瘤中的“干性”进行探索。新出现的数据强烈暗示胶质瘤内存在转化的多能细胞,其中一小部分细胞在肿瘤起始方面表现出更高的效率。然而,迄今为止,支持真正的胶质瘤干细胞的数据尚无定论,尤其是在这些细胞的功能特征方面。正在进行的工作旨在确定调控这些假定干细胞自我更新的独特途径,并将其验证为最终的治疗靶点。